JNK India Posts Strong Q1FY27 Results: Revenue Up 80.6%, PAT Up 8.5x
JNK India reported a strong Q1FY27 with consolidated revenue up 80.6% YoY to ₹186 Cr and PAT up 8.5x. Standalone revenue grew 65.7% to ₹170 Cr. The company maintains an order book of ₹1,801 Cr and guides for FY27 EBITDA margins of 14-15% with 25-30% revenue growth.
The substantial increase in revenue and profit, coupled with a strong order book and positive future guidance, indicates a significant positive impact on the company's financial health and investor outlook.
The company reported significant year-on-year growth in revenue and profit, exceeding expectations and demonstrating strong financial performance. Positive margin guidance for FY27 further reinforces the positive sentiment.
JNK India Limited announced its financial results for the first quarter of FY27 (ended June 2026), reporting a significant year-on-year growth. The consolidated total revenue surged by 80.6% to ₹186 crore, with EBITDA growing 3.1 times and Profit After Tax (PAT) increasing by a remarkable 8.5 times. The consolidated EBITDA margin stood at 11.8%, and PAT margin was 5.2%.
On a standalone basis, JNK India also witnessed substantial growth. Total revenue grew by 65.7% to ₹170 crore. Standalone EBITDA saw a 3.1x increase, and PAT grew by 11.6 times. The standalone EBITDA margin was reported at 14.0%, with a PAT margin of 8.2%.
Notably, the Q1FY27 consolidated total income includes revenue of ₹16.5 crore from JNK Chemdist Limited, which was not part of the group in Q1FY26. The company has an order book of ₹1,801 crore as of June 2026, providing revenue visibility for the next two years.
JNK India also provided margin guidance, indicating it is on track to achieve an EBITDA margin of 14-15% and revenue growth of 25-30% for FY27. The company previously announced its participation in the Emkay Global Conference, where investors and analysts were briefed about the company's performance and outlook. The investor presentation discussed during the meeting has been enclosed.
What to do with a filing like this
JNK India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by JNK India Limited. Read the original for the full detail.